Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notice to Readers: Expansion of Eligibility for Influenza Vaccine Through
the Vaccines for Children Program
On June 20, 2002, the Advisory Committee on Immunization Practices (ACIP) adopted a resolution expanding the
group of children eligible for influenza vaccine coverage under the Vaccines for Children (VFC) program. The resolution
extends VFC coverage for influenza vaccine to all VFC-eligible children aged 6--23 months and VFC-eligible children aged 2--18
years who are household contacts of children aged <2 years. The resolution becomes effective on March 1, 2003, for vaccine to be administered during the 2003--04 influenza vaccination season and subsequent seasons. ACIP is expanding VFC influenza coverage because children aged
<23 months are at substantially increased risk for influenza-related hospitalizations.
For the upcoming 2002--03 influenza season, no changes are being made to groups of children eligible for influenza vaccine under the VFC program. Children aged 6 months--18 years who are eligible for the VFC program and who have a
high-risk medical condition or are household members of a person at high risk for complications may receive influenza vaccine through the program. Groups of children with high-risk medical conditions include those who 1) have chronic disorders of
the pulmonary or cardiovascular systems, including asthma; 2) have required medical follow-up or hospitalization during
the preceding year because of chronic metabolic diseases (including diabetes mellitus), renal dysfunction, hemoglobinopathies, or immunosuppression (including immunosuppression caused by medications); 3) are receiving long-term aspirin therapy; 4)
are residents of long-term care facilities; and 5) are adolescent females in the second or third trimester of pregnancy during
the influenza season (typically November--March).
The availability of additional supplies of influenza vaccine through the VFC program for the 2003--04 season will be
based on anticipated need. VFC providers should provide their state's vaccination program with accurate and practical estimates of the number of VFC patients they plan to vaccinate. Accurate estimates are essential to ensure an adequate supply of
vaccine and to avoid vaccine wastage. ACIP
recommendations for the 2002--03 influenza season are available at
http://www.cdc.gov/nip/flu/target-groups.htm and
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5103a1.htm. Information about the VFC program is available at
http://www.cdc.gov/nip/vfc. The VFC Resolution for Influenza Vaccine (10/98-4), effective during the 2002--03 season, is available at
http://www.cdc.gov/nip/vfc/flu.pdf.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
